DJIA51654.95 492.55
S&P 5007811.54 55.62
NASDAQ27366.17 196.13
Russell 20002806.98 18.70
German DAX25087.27 264.22
FTSE 10010552.05 110.45
CAC 407803.33 73.64
EuroStoxx 506176.15 53.80
Nikkei 22569030.92 -11.19
Hang Seng24211.35 425.56
Shanghai Comp3813.79 1.89
KOSPI6625.93 -177.97
Bloomberg Comm IDX143.93 0.07
WTI Crude-fut104.43 -0.01
Brent Crude-fut91.66 0.18
Natural Gas3.20 0.04
Gasoline-fut3.27 -0.06
Gold-fut4220.30 72.30
Silver-fut61.11 1.85
Platinum-fut1695.40 50.50
Palladium-fut1150.00 22.50
Copper-fut6.71 0.14
Aluminum-spot3195.00 0.00
Coffee-fut285.15 -2.70
Soybeans-fut1292.25 5.75
Wheat-fut670.75 -12.75
Bitcoin82555.88 1119.02
Ethereum USD2487.71 41.06
Litecoin63.77 1.56
Dogecoin0.08 0.00
EUR/USD1.1198 0.0006
USD/JPY158.29 0.32
GBP/USD1.3218 -0.0008
USD/CHF0.8343 0.0003
USD IDX102.23 0.05
US 10-Yr TR5.242 0.009
GER 10-Yr TR3.484 -0.022
UK 10-Yr TR5.449 -0.039
JAP 10-Yr TR3.016 -0.068
Fed Funds4 0
SOFR3.87 -0.01
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + VC  | 
Healthcare-Focused Martis Capital Closes Largest Fund Ever at $779M

Healthcare-Focused Martis Capital Closes Largest Fund Ever at $779M 

Martis Capital Management, LLC, a San Francisco, CA and Washington, DC-based healthcare-focused private equity firm, closed its fourth fund and largest to date, Martis Partners IV, LP, at $779 million. 

The firm launched the fund in 2022 targeting $700 million with a hard cap of $750 million. With the new fund, the firm has raised more than $2.1 billion in capital to date. 

Martis Capital has made three investments from Fund IV in companies specializing in clinical research trials, value-based primary care and dental care, including Rise Health and Alcanza Clinical Research, which it purchased in October. 

“Fund IV, our largest to date, is off to a great start. Our three initial investments are performing well, a testament to the quality of our partner companies and the research and due diligence of the Martis Capital team,” said Owen Davis, managing partner. 

Previously known as Capricorn Healthcare, the firm closed its third fund at $550 million in 2018 and raised a combined $600 million for its inaugural and sophomore fund. 

Martis Capital invests in buyout and growth equity opportunities in middle-market companies within the services and outsourcing, IT and consumer and wellness subsectors of the healthcare industry. 

Don’t miss the Connect Money: Alternative Assets Conference on June 14 in Chicago at the W City Center. Connect in person with industry experts like Glenn Spencer, CEO Prime Capital Investment Advisors. 

Connect

Inside The Story

Martis Capital

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.